SSA
JAZZ icon

Schonfeld Strategic Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Schonfeld Strategic Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7M Sell
62,142
-77,075
-55% -$13.5M 0.08% 263
2025
Q4 		$23.7M Sell
139,217
-297,226
-68% -$45.6M 0.1% 164
2025
Q3 		$57.5M Buy
436,443
+373,383
+592% +$44.8M 0.33% 34
2025
Q2 		$6.69M Buy
63,060
+35,890
+132% +$3.9M 0.05% 464
2025
Q1 		$3.37M Sell
27,170
-2,147
-7% -$280K 0.02% 686
2024
Q4 		$3.61M Sell
29,317
-65,533
-69% -$7.72M 0.02% 613
2024
Q3 		$10.6M Buy
+94,850
New +$10.4M 0.07% 286
2024
Q1 		– Sell
-4,311
Closed -$530K – 2230
2023
Q4 		$530K Buy
+4,311
New +$538K ﹤0.01% 1270
2022
Q3 		– Sell
-21,099
Closed -$3.29M – 3072
2022
Q2 		$3.29M Buy
+21,099
New +$3.25M 0.03% 590
2021
Q2 		– Sell
-20,531
Closed -$3.37M – 2116
2021
Q1 		$3.37M Buy
+20,531
New +$3.38M 0.04% 538
2019
Q3 		– Sell
-1,489
Closed -$212K – 1125
2019
Q2 		$212K Buy
+1,489
New +$200K 0.01% 876
2017
Q2 		– Sell
-7,402
Closed -$1.07M – 691
2017
Q1 		$1.07M Buy
+7,402
New +$964K 0.11% 246

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Schonfeld Strategic Advisors's JAZZ Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 55% in Q1 2026, selling an estimated $13.5M and leaving 62,142 shares worth $11.7M. The position accounts for 0.08% of the portfolio, ranked #263.

Schonfeld Strategic Advisors first reported a position in JAZZ in Q1 2017 and has held it in 12 quarters since. The position peaked at $57.5M in Q3 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Schonfeld Strategic Advisors held 62,142 shares of Jazz Pharmaceuticals worth $11.7M as of Q1 2026.
  • Schonfeld Strategic Advisors sold 77,075 Jazz Pharmaceuticals shares in Q1 2026, an estimated $13.5M.
  • Jazz Pharmaceuticals made up 0.08% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #263 holding.
  • Schonfeld Strategic Advisors first reported a position in Jazz Pharmaceuticals in Q1 2017 and has held it in 12 quarters since.
  • Schonfeld Strategic Advisors's Jazz Pharmaceuticals position peaked at $57.5M in Q3 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.